COVID-19 Impact on Endometriosis Therapies Market, Global Research Reports 2020-2021

COVID-19 Impact on Endometriosis Therapies Market, Global Research Reports 2020-2021

Table of Contents
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Endometriosis Therapies Industry
1.7 COVID-19 Impact: Endometriosis Therapies Market Trends
2 Global Endometriosis Therapies Quarterly Market Size Analysis
2.1 Endometriosis Therapies Business Impact Assessment - COVID-19
2.1.1 Global Endometriosis Therapies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Endometriosis Therapies Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Endometriosis Therapies Quarterly Market Size, 2019 VS 2020
3.2 By Players, Endometriosis Therapies Headquarters and Area Served
3.3 Date of Key Players Enter into Endometriosis Therapies Market
3.4 Key Players Endometriosis Therapies Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Endometriosis Therapies Segments, By Type
4.1 Introduction
1.4.1 Hormonal Contraceptives
1.4.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
1.4.3 Progestin Therapy
1.4.4 Aromatase Inhibitors
4.2 By Type, Global Endometriosis Therapies Market Size, 2019-2021
5 Impact of Covid-19 on Endometriosis Therapies Segments, By Application
5.1 Overview
5.5.1 Hospital
5.5.2 Clinic
5.5.3 Other
5.2 By Application, Global Endometriosis Therapies Market Size, 2019-2021
5.2.1 By Application, Global Endometriosis Therapies Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Business Overview
7.1.2 AbbVie Endometriosis Therapies Quarterly Revenue, 2020
7.1.3 AbbVie Endometriosis Therapies Product Introduction
7.1.4 AbbVie Response to COVID-19 and Related Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Business Overview
7.2.2 Eli Lilly Endometriosis Therapies Quarterly Revenue, 2020
7.2.3 Eli Lilly Endometriosis Therapies Product Introduction
7.2.4 Eli Lilly Response to COVID-19 and Related Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Business Overview
7.3.2 AstraZeneca Endometriosis Therapies Quarterly Revenue, 2020
7.3.3 AstraZeneca Endometriosis Therapies Product Introduction
7.3.4 AstraZeneca Response to COVID-19 and Related Developments
7.4 Bayer
7.4.1 Bayer Business Overview
7.4.2 Bayer Endometriosis Therapies Quarterly Revenue, 2020
7.4.3 Bayer Endometriosis Therapies Product Introduction
7.4.4 Bayer Response to COVID-19 and Related Developments
7.5 Astellas Pharma
7.5.1 Astellas Pharma Business Overview
7.5.2 Astellas Pharma Endometriosis Therapies Quarterly Revenue, 2020
7.5.3 Astellas Pharma Endometriosis Therapies Product Introduction
7.5.4 Astellas Pharma Response to COVID-19 and Related Developments
7.6 Meditrina Pharmaceuticals
7.6.1 Meditrina Pharmaceuticals Business Overview
7.6.2 Meditrina Pharmaceuticals Endometriosis Therapies Quarterly Revenue, 2020
7.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Product Introduction
7.6.4 Meditrina Pharmaceuticals Response to COVID-19 and Related Developments
7.7 Pfizer
7.7.1 Pfizer Business Overview
7.7.2 Pfizer Endometriosis Therapies Quarterly Revenue, 2020
7.7.3 Pfizer Endometriosis Therapies Product Introduction
7.7.4 Pfizer Response to COVID-19 and Related Developments
7.8 Neurocrine Biosciences
7.8.1 Neurocrine Biosciences Business Overview
7.8.2 Neurocrine Biosciences Endometriosis Therapies Quarterly Revenue, 2020
7.8.3 Neurocrine Biosciences Endometriosis Therapies Product Introduction
7.8.4 Neurocrine Biosciences Response to COVID-19 and Related Developments
7.9 Takeda Pharmaceutical
7.9.1 Takeda Pharmaceutical Business Overview
7.9.2 Takeda Pharmaceutical Endometriosis Therapies Quarterly Revenue, 2020
7.9.3 Takeda Pharmaceutical Endometriosis Therapies Product Introduction
7.9.4 Takeda Pharmaceutical Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer

List of Tables
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Endometriosis Therapies Assessment
Table 9. COVID-19 Impact: Endometriosis Therapies Market Trends
Table 10. COVID-19 Impact Global Endometriosis Therapies Market Size
Table 11. Global Endometriosis Therapies Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Endometriosis Therapies Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Endometriosis Therapies Market Growth Drivers
Table 14. Global Endometriosis Therapies Market Restraints
Table 15. Global Endometriosis Therapies Market Opportunities
Table 16. Global Endometriosis Therapies Market Challenges
Table 17. By Players, Endometriosis Therapies Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Endometriosis Therapies Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Endometriosis Therapies Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Endometriosis Therapies Market
Table 21. Key Players Endometriosis Therapies Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Endometriosis Therapies Market Size 2019-2021, (US$ Million)
Table 24. Global Endometriosis Therapies Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Endometriosis Therapies Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Endometriosis Therapies Market Size, 2019-2021 (US$ Million)
Table 57. AbbVie Business Overview
Table 58. AbbVie Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. AbbVie Endometriosis Therapies Product
Table 60. AbbVie Response to COVID-19 and Related Developments
Table 61. Eli Lilly Business Overview
Table 62. Eli Lilly Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Eli Lilly Endometriosis Therapies Product
Table 64. Eli Lilly Response to COVID-19 and Related Developments
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. AstraZeneca Endometriosis Therapies Product
Table 68. AstraZeneca Response to COVID-19 and Related Developments
Table 69. Bayer Business Overview
Table 70. Bayer Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Bayer Endometriosis Therapies Product
Table 72. Bayer Response to COVID-19 and Related Developments
Table 73. Astellas Pharma Business Overview
Table 74. Astellas Pharma Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Astellas Pharma Endometriosis Therapies Product
Table 76. Astellas Pharma Response to COVID-19 and Related Developments
Table 77. Meditrina Pharmaceuticals Business Overview
Table 78. Meditrina Pharmaceuticals Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Meditrina Pharmaceuticals Endometriosis Therapies Product
Table 80. Meditrina Pharmaceuticals Response to COVID-19 and Related Developments
Table 81. Pfizer Business Overview
Table 82. Pfizer Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Pfizer Endometriosis Therapies Product
Table 84. Pfizer Response to COVID-19 and Related Developments
Table 85. Neurocrine Biosciences Business Overview
Table 86. Neurocrine Biosciences Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Neurocrine Biosciences Endometriosis Therapies Product
Table 88. Neurocrine Biosciences Response to COVID-19 and Related Developments
Table 89. Takeda Pharmaceutical Business Overview
Table 90. Takeda Pharmaceutical Endometriosis Therapies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Takeda Pharmaceutical Endometriosis Therapies Product
Table 92. Takeda Pharmaceutical Response to COVID-19 and Related Developments

List of Figures
Figure 1. Endometriosis Therapies Product Picture
Figure 2. Endometriosis Therapies Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Endometriosis Therapies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Endometriosis Therapies Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Endometriosis Therapies Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Endometriosis Therapies Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Endometriosis Therapies Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Endometriosis Therapies Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Endometriosis Therapies Market Size Market Share, 2019-2021

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Dextran - Global Market Insights and Sales Trends 2024 -2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 122

The global Dextran market was valued at US$ 234.14 million in 2022 and it will reach US$ 346.64 million by the end of 2029, growing at a CAGR of 5.97% during 2023-2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Dextran, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed bu......

Global Corticosteroids API Market Research Report 2023

Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 162

The global Corticosteroids API market was valued at US$ 2206.26 million in 2022 and is anticipated to reach US$ 3309.40 million by 2029, witnessing a CAGR of 6.11% during the forecast period 2023-2029. North American market for Corticosteroids API is estimated to increase from $ 220.53 million in 2022 to reach $ 302.18 million by 2029, at a CAGR of 4.69 % during the forecast period of 2023 through 2029. Europe market for Corticosteroids API is estimated to increase from $ 512.79 mi......

Global HPLC Columns Market Research Report 2023

Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 149

The global HPLC Columns market was valued at US$ 1823.16 million in 2022 and is anticipated to reach US$ 2674.78 million by 2029, witnessing a CAGR of 6.37% during the forecast period 2023-2029. The major global manufacturers of HPLC Columns include Agilent, Waters Corporation, Shimadzu, Thermo Fisher Scientific, Danaher, Hamilton, Merck, Bio - Rad, and Restek, etc. In 2022, the world's top three vendors accounted for approximately 48.41 % of the revenue. Report Scope This r......

Global Inorganic Advanced Phase Change Materials Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Inorganic Advanced Phase Change Materials market was valued at US$ 960.3 million in 2023 and is anticipated to reach US$ 2087.3 million by 2030, witnessing a CAGR of 11.9% during The forecast period 2024-2030. North American market for Inorganic Advanced Phase Change Materials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Inorganic Advanced Phase Ch......

Global Material Jetting 3D Printing Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Material Jetting 3D Printing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Material Jetting 3D Printing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Material Jetting 3D Printing is estimated to increase from $ million i......

Global Halogen Free Material Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 81

The global Halogen Free Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ mil......

Global Silicone Adhesives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 101

The global Silicone Adhesives market was valued at US$ 1999.8 million in 2023 and is anticipated to reach US$ 2628.8 million by 2030, witnessing a CAGR of 3.5% during The forecast period 2024-2030. North American market for Silicone Adhesives is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Silicone Adhesives is estimated to increase from $ million in 2023 to rea......

Global Paraffin Hydrotreating Catalyst Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 91

The global Paraffin Hydrotreating Catalyst market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Paraffin Hydrotreating Catalyst is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Paraffin Hydrotreating Catalyst is estimated to increase from $ ......

Global Stained Glass Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Stained Glass market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs